Granulomatous lung disease occurring during etanercept treatment

被引：60

作者：

Phillips, K ^{[1
]}

Weinblatt, M ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA

来源：

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2005年 / 53卷 / 04期

关键词：

D O I：

10.1002/art.21336

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：618 / 620

页数：3

共 10 条

[1]

Bean AGD, 1999, J IMMUNOL, V162, P3504

[2] Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].

Braun, J ;

Brandt, J ;

Listing, J ;

Zink, A ;

Alten, R ;

Golder, W ;

Gromica-Ihle, E ;

Kellner, H ;

Krause, A ;

Schneider, M ;

Sörensen, H ;

Zeidler, H ;

Thriene, W ;

Sieper, J .

LANCET, 2002, 359 (9313) :1187-1193

[3] PULMONARY SARCOIDOSIS - A DISORDER MEDIATED BY EXCESS HELPER LYMPHOCYTE-T ACTIVITY AT SITES OF DISEASE-ACTIVITY [J].

HUNNINGHAKE, GW ;

CRYSTAL, RG .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (08) :429-434

[4] Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent [J].

Keane, J ;

Gershon, S ;

Wise, RP ;

Mirabile-Levens, E ;

Kasznica, J ;

Schwieterman, WD ;

Siegel, JN ;

Braun, MM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (15) :1098-1104

[5] Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-α therapy [J].

Mallbris, L ;

Ljungberg, A ;

Hedblad, MA ;

Larsson, P ;

Ståhle-Bäckdahl, M .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (02) :290-293

[6] Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-α [J].

Olleros, ML ;

Guler, R ;

Corazza, N ;

Vesin, D ;

Eugster, HP ;

Marchal, G ;

Chavarot, P ;

Mueller, C ;

Garcia, I .

JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3394-3401

[7] Lung injury linked to etanercept therapy [J].

Peno-Green, L ;

Lluberas, G ;

Kingsley, T ;

Brantley, S .

CHEST, 2002, 122 (05) :1858-1860

[8] Infliximab for the treatment of fistulas in patients with Crohn's disease [J].

Present, DH ;

Rutgeerts, P ;

Targan, S ;

Hanauer, SB ;

Mayer, L ;

van Hogezand, RA ;

Podolsky, DK ;

Sands, BE ;

Braakman, T ;

DeWoody, KL ;

Schaible, TF ;

van Deventer, SJH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (18) :1398-1405

[9]

TUMANG MCT, 1994, J IMMUNOL, V153, P768

[10] Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy [J].

Vavricka, SR ;

Wettstein, T ;

Speich, R ;

Gaspert, A ;

Bachli, EB .

THORAX, 2003, 58 (03) :278-279

← 1 →